Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I came across some news about ZEO ScientifiX, partnering with Exotropin to launch a new hair growth product called ZEO HAIR GROW™. This one caught my eye because it’s combining extracellular vesicles (EVs) from sources like amniotic fluid and stromal cells with natural ingredients, which is not something I’ve seen often in hair regrowth treatments.
From what I’ve read, they’re rolling it out at a medical aesthetics conference this week, and it sounds like they’re trying to tackle a big market here, with hair loss affecting millions in the U.S. alone. Curious if anyone else has looked into this company or has thoughts on partnerships like these in the biotech world.
https://finance.yahoo.com/news/zeo-scientifix-exotropin-join-forces-110000702.html
OCEL: effective March 5,2024 Organicell Regenerative Medicine Inc, OCEL, will change to Zeo ScientifiX Inc, ZEOX:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
There aren't many shares after the RS so it'll move.
Thank you - I think the thing that bothers me most over the last year is the lack of news.
After all the changes in leadership, the money they sunk into Ocel … etc… the lack of news is interesting.
Maybe something is brewing again. Lol Let’s go $20. We are only $16.80 away
Wishing you the best Blue!
Interesting action as of late. Nice increases.
I’m trying to find news as to what’s happening and cannot. However, we are hovering close to $3.50 a share now.
Let’s go! And let there be great news.
OTC is a crap shoot. I have a few stocks where management is very quite. The new Regulations may have company's worried about what they say and do.
Ocel got flagged for something like that as well. Best of luck to you. Hopefully the OTC makes a turn around and volume will pick up. But as far as I'm concerned everything is a shit show as well as the stock market.
Hopefully the country gets it right this time in 2024 or I'll be moving to Mexico and praying they don't cut social security .
Good luck. If they get FDA approval to move forward things can change fast. I met a guy on a plane. 62, a healthy firefighter that suddenly got sick. He needs a heart transplant and all they tell him it has something to do with covid....
I still have a decent amount of shares. It would take a significant run to get me back to even. Made money in covid run too.
I’m not holding my breath right now. I really don’t like R/S’s. It tends to be the kiss of death to value 95% of the time.
They’re not putting out any news. No news about internal structure… or product. I was hopeful with the management changes.
Fortunately I made some $ when they had their covid run.
Yes, has rs’d twice pass 3 years 1st split my shares down to 12. Last split down to one.
Do you have many shares left post split? I dumped most. Was it 500 to 1 split?
They stated it would crush retail. If the drug gets FDA approval it should take off.
Still around! It’s been very busy.
Saw the r/s was approved.
OCEL: effective Nov. 28,2023 a one for 200 reverse split:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
They have been Very transparent that this RSb1 for 500bshares will happen
Did they announce that was happening. Or did it get approved? I lost track for a bit.
They’re definitely dipping today
Yup terrible for retail
1 share for every 500. Bye bye retail
I dumped half my holding here as soon as I heard RS. And my luck they'll get a big cash infusion from a gooverment grant.
Long odds on it uplisting, not many .01 stocks make it to the big boards.
BUT, insiders did buy 2.77 million shares in the past month or so so something is about to happen. Most of the buys were sub penny.
Watching from the sidelines unless my bait get grabbed.
Well if they were going to follow it with an immediate uplist it could work but in most cases the stock will get shorted to hell and back.
The ratio is up to 300 to 1 - that's not just a lil share structure adjustment - that is crap you would see the gooberment do.
Well anytime there's a mention of reverse split the stock price tanks. So far she's holding up.
Well there it is. Figured it would happen.
So the drug looks good safety wise. P 2 is on deck, but will require Funding. At 2 pennies a share selling shares won't cut it. They need grants or maybe even some type of partnership.
Perhaps the company is getting smart and will stop trying to raise funds when the momo isn't there?
They are recruiting for a trial at this time.Not sure why you said they're not in trials? Wish we could get an update but the crooked OTC slapped them with some BS and they maybe playing there hand close to the chest
Yup, well, there ya go. Down 16% today. If this thing did hit and actually had real trials that worked and FDA approved, I'd be set I think. Good luck.
-OUT-
I was referring to in the "short term" not my long term outlook.
I've been here since they first announced having a potential covid drug 3 ish years ago. I buy n sell their shares as I see fit. If this trend keeps going up I will be a very happy investor.
GLTU looking at the chart it appears the trend is going up and hope it sustains higher highs and lows. Good timing on your part.
lol, thought you were 'suckered' in last time?
Folks sitting on the fence may want to start accumulating .
I got suckered in to buying the last time it popped only to have it drop back down under a penny.
Also looks like the old director has resigned… the one they accused of mishandling business.
Turn around coming? Wish I had bought more lower.
Looks like more insider investment over the last couple days
Yup, don't know what it will amount too.
Pretty Weighty... Did anyone see this?
http://archive.fast-edgar.com/20230609/APZ2L22CN222M2ZH222B22ZYGM3Q422SZ252/
Ba s tards taking it back. Faked me into buying rinse n repeat
It sure seems like we are basing at a new level.
That's because of them getting that slap on the wrist by the Regulators maybe. Also as long as they are recruiting there really is nothing to report. Recruiting is expected to last till the end of this year
It’s interesting as there is absolutely no news. Nothing more from new management. Etc.
I'd keep cash on hand and keep an eye out for news so you can buy asap if news hits. I don't think there are many eyes on this.
It’s tempting to buy more. But there’s absolutely no news. Everything went silent
I'm seeing more energy in otc plays.
Ocel has backing to finance this P1 trial for a unmet issue copd. Especially when covid really does damage to those with these pre conditions.
Price is right for a Risk Reward play
Let's see where we are end of week..
Is the bottom in?